Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycythemia Vera × Clopidogrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thromboembolism 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Polycythemia Vera 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

fludarabine phosphate 17 Cyclophosphamide 15 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 10 ruxolitinib 9 Mycophenolic Acid 9 Busulfan 9 Tacrolimus 8 fludarabine 7 Radiotherapy 5 Methotrexate 5 Cyclosporine 5 Aspirin 5 Melphalan 4 Imatinib Mesylate 4 Biopsy 4 Antilymphocyte Serum 4 peginterferon alfa-2a 3 givinostat hydrochloride 3 givinostat 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Decitabine 3 bomedemstat 2 Surveys and Questionnaires 2 Methylprednisolone 2 Lenalidomide 2 Filgrastim 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00940784 2014-11-26

ISCLAP

Icahn School of Medicine at Mount Sinai

Phase 2 Withdrawn

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡